Premium
Is stand‐alone D‐dimer testing safe to rule out acute pulmonary embolism?
Author(s) -
Es N.,
Hulle T.,
Büller H. R.,
Klok F. A.,
Huisman M. V.,
Galipienzo J.,
Di Nisio M.
Publication year - 2017
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/jth.13574
Subject(s) - d dimer , pulmonary embolism , medicine , post hoc , post hoc analysis , predictive value
Essentials A stand‐alone D‐dimer below 750 μg/L has been proposed to rule out acute pulmonary embolism (PE). This was a post‐hoc analysis on data from 6 studies comprising 7268 patients with suspected PE. The negative predictive value of a D‐dimer <750 μg/L ranged from 79% to 96% in various subgroups. Stand‐alone D‐dimer testing seems to be unsafe to rule out PE in all patients.Summary Background Recently, stand‐alone D‐dimer testing at a positivity threshold of 750 μg L −1 has been proposed as a safe and efficient approach to rule out acute pulmonary embolism ( PE ), without additional imaging, but this approach needs validation. Objectives To evaluate stand‐alone D‐dimer testing at a positivity threshold of 750 μg L −1 to rule out PE . Methods Individual data from 7268 patients with suspected PE previously enrolled in six prospective management studies were used. Patients were assessed by the Wells rule followed by quantitative D‐dimer testing in those with a ‘ PE unlikely’ score. Patients were classified post hoc as having a negative (< 750 μg L −1 ) or positive (≥ 750 μg L −1 ) D‐dimer. Using a one‐stage meta‐analytic approach, the negative predictive value ( NPV ) of stand‐alone D‐dimer testing was evaluated overall and in different risk subgroups. Results The pooled incidence of PE was 23% (range, 13–42%). Overall, 44% of patients had a D‐dimer < 750 μg L −1 , of whom 2.8% were diagnosed with PE at baseline or during 3‐month follow‐up ( NPV , 97.2%; 95% confidence interval [ CI ], 94.9–98.5). The NPV was highest in patients with a low probability of PE according to the Wells rule (99.2%; 95% CI , 98.6–99.5%) and lowest in those with a high probability of PE (79.3%; 95% CI , 53.0–92.8%). The NPV s in patients with active cancer, patients with previous venous thromboembolism and inpatients were 96.2% (95% CI , 85.6–99.1%), 94.7% (95% CI , 88.6–97.6%) and 92.7% (95% CI , 79.3–97.7%), respectively. Conclusions Our findings suggest that stand‐alone D‐dimer testing at a positivity threshold of 750 μg L −1 is not safe to rule out acute PE .